Key Takeaways

  • Opioid use disorder (OUD) is diagnosed using 11 DSM-5 criteria — meeting 2 or more indicates OUD. Meeting 6 or more is severe.
  • Signs span physical (tolerance, withdrawal, track marks), behavioral (financial problems, social withdrawal, drug-seeking), and psychological (cravings, denial, preoccupation).
  • The fentanyl crisis means any active illicit opioid use — including prescription misuse — now carries immediate overdose risk with every single use.
  • OUD is highly treatable. FDA-approved MAT reduces overdose deaths by up to 50%. Waiting for “rock bottom” costs lives.
  • If you recognize these signs in yourself or a loved one, call (844) 561-0606 — treatment can begin same-day.

Opioid use disorder develops gradually — often invisibly. By the time the signs become undeniable, the person has typically been struggling for months or years. Recognizing the signs early — before an overdose — is the difference between getting help and receiving a phone call you can never unhear. This guide covers the clinical criteria, physical signs, behavioral warning signs, and exactly what to do if you recognize them in yourself or someone you love.

The Scale of the Opioid Crisis

According to SAMHSA’s 2023 National Survey on Drug Use and Health, approximately 6.1 million Americans aged 12 or older had opioid use disorder in the past year. The CDC reports that opioids were involved in more than 80,000 overdose deaths in 2023, with illicitly manufactured fentanyl and fentanyl analogs driving the overwhelming majority. Despite these numbers, NIDA estimates that fewer than 25% of people with OUD receive any form of treatment in a given year.

6.1M
Americans with opioid use disorder in 2023 (SAMHSA)
80,000+
Opioid overdose deaths in the US in 2023 (CDC)
<25%
of people with OUD who receive treatment in a given year (NIDA)

The DSM-5 Criteria: What Clinicians Look For

A clinical diagnosis of opioid use disorder requires meeting at least 2 of 11 criteria from the DSM-5 within a 12-month period. Severity is graded: 2–3 criteria is mild OUD; 4–5 is moderate; 6 or more is severe. You do not need to be injecting heroin to meet the criteria for severe opioid use disorder — prescription opioid misuse accounts for a significant share of diagnoses.

  1. Taking opioids in larger amounts or for longer than intended
  2. Persistent desire or unsuccessful efforts to cut down or control use
  3. Spending a great deal of time obtaining, using, or recovering from opioids
  4. Cravings or strong urges to use opioids
  5. Failure to fulfill major obligations at work, school, or home due to opioid use
  6. Continued use despite persistent or recurring social or interpersonal problems caused or worsened by opioids
  7. Giving up or reducing important social, occupational, or recreational activities because of opioid use
  8. Using opioids in physically hazardous situations (driving, operating machinery)
  9. Continued use despite knowing it causes or worsens a physical or psychological problem
  10. Tolerance — needing markedly more opioids to achieve the same effect, or markedly diminished effect with the same amount
  11. Withdrawal — experiencing the characteristic opioid withdrawal syndrome, or taking opioids to relieve or avoid withdrawal symptoms

Tolerance and Withdrawal Don’t Automatically Mean Addiction

Criteria 10 and 11 do not count toward an OUD diagnosis when opioids are taken solely as prescribed under legitimate medical supervision. Physical dependence alone does not equal addiction. However, tolerance and physical dependence in someone using opioids outside of medical supervision are significant warning signs.

Physical Signs of Opioid Addiction

1. Constricted “Pinpoint” Pupils

Opioids cause very small pupils even in low-light conditions — one of the most reliable physical signs of recent opioid use, and one of three signs EMS checks for in suspected overdose. If someone’s pupils appear abnormally small regardless of lighting, opioid use should be suspected.

2. Nodding Off or Unpredictable Sedation

Profound sedation at inappropriate times — mid-conversation, mid-meal, or mid-activity — is distinct from normal drowsiness. Opioid intoxication produces a characteristic “on the nod” state that occurs at predictable intervals after use and is not explained by normal fatigue or sleep deprivation.

3. Track Marks and Injection Sites

For people who inject opioids, needle marks, bruising, or scarring along veins — particularly in the inner arms, hands, feet, or neck — are visible signs of intravenous use. Wearing long sleeves in warm weather, frequently visiting the bathroom, and covering arms or legs are common behavioral accompaniments. Injection drug use also carries risks of endocarditis, abscesses, and blood-borne infections including HIV and hepatitis C.

4. Withdrawal Symptoms When Not Using

Opioid withdrawal is intensely physically uncomfortable and begins 8–24 hours after the last dose, depending on the opioid. Symptoms include severe muscle and bone aches, restless leg syndrome, profound anxiety and irritability, yawning, runny nose, sweating, goosebumps, nausea, vomiting, and diarrhea. People often describe it as the worst flu imaginable. A pattern of “flu symptoms” that appear cyclically and resolve when the person disappears and returns is a telling family observation.

5. Significant Weight Loss and Neglect of Appearance

Opioids suppress appetite and consume the time and energy that would otherwise go toward self-care. Unexplained weight loss, deteriorating dental health (“opioid mouth”), and declining personal hygiene are observable physical signs of addiction-driven self-neglect.

6. Slurred Speech and Poor Coordination

At intoxicating doses, opioids produce slurred speech, slowed reaction time, and impaired coordination. These signs during waking hours — particularly at consistent times of day — are behaviorally observable indicators of active use.

Behavioral Signs of Opioid Addiction

7. Escalating Financial Problems

Illicit opioid addiction is expensive. Heroin or fentanyl habits can cost $100–$300 or more per day. Signs include persistent requests to borrow money, selling personal possessions, missing bill payments, unexplained ATM withdrawals, and eventually theft from family members or employers. Financial deterioration is often the most visible early behavioral sign for family members.

8. Social Withdrawal and Relationship Deterioration

Prior friendships, family relationships, and social activities progressively replaced by the network and schedule surrounding drug use. The person becomes increasingly secretive about their whereabouts, avoids family events, and may introduce a new social circle their family has never met. Relationships that were previously close become strained or severed.

9. Declining Work or School Performance

Unexplained absences, missed deadlines, performance decline, disciplinary problems, or outright job loss are common consequences of active opioid addiction. The time consumed by obtaining, using, and recovering from opioids leaves insufficient capacity for sustained professional or academic function.

10. Drug-Seeking Behaviors

Doctor shopping (visiting multiple providers to obtain prescriptions), requesting specific opioids by name, fabricating or exaggerating injuries to obtain prescriptions, stealing medications from family members or medicine cabinets, and purchasing from illicit online sources or street dealers are all drug-seeking behaviors that indicate loss of control over use.

Psychological Signs of Opioid Addiction

11. Dramatic and Unexplained Mood Swings

The cycle of opioid intoxication (euphoria, sedation, emotional blunting) followed by withdrawal onset (anxiety, agitation, dysphoria, irritability) produces dramatic mood fluctuations at predictable intervals that are not explained by external circumstances. Family members often describe the person as being “two different people” depending on when they last used.

12. Denial and Minimization

Denial is a neurobiological feature of addiction, not a character flaw. Changes in prefrontal cortex function — the brain region responsible for accurate self-assessment and executive control — impair the person’s ability to objectively evaluate the severity of their problem. Most people with OUD genuinely underestimate how serious their situation is. This is not dishonesty; it is a symptom of the disease itself.

What Family Members Should Watch For

Family members are often the first to notice warning signs, frequently before the person themselves acknowledges a problem. Specific things to watch for:

  • Unexplained disappearances for hours at a time, particularly at consistent times of day
  • Frequent bathroom visits, particularly after meals (a common injection location)
  • Missing prescription medications — yours or theirs — from medicine cabinets
  • Paraphernalia: hypodermic needles, spoons with burn marks, aluminum foil with residue, small plastic bags, cotton balls
  • Pinpoint pupils and sedation alternating with agitation and flu-like symptoms on a predictable cycle
  • Unusual financial requests, missing cash, or missing valuables from the home
  • Increasing isolation from family and prior social network; a new and secretive social circle
  • Defensive or hostile reactions to any questions about their behavior or whereabouts

For Families: CRAFT Is the Most Evidence-Based Approach

Community Reinforcement and Family Training (CRAFT) is the most extensively researched family intervention model for addiction. It outperforms both Al-Anon participation and confrontational “intervention” models in getting loved ones into treatment. Ask our specialists about CRAFT-based family guidance when you call (844) 561-0606.

The Fentanyl Factor: Why Waiting Is No Longer an Option

No “Safe” Level of Illicit Opioid Use Exists in 2026

According to the DEA, virtually all street opioids in the US — including substances sold as heroin, oxycodone, Xanax, and Adderall — are now contaminated with illicitly manufactured fentanyl or its analogs. A dose tolerated dozens of times can be fatal if it contains a slightly higher fentanyl concentration, or if tolerance has dropped after any period of reduced use. There is no safe dose, no safe source, and no predictable threshold.

The concept of waiting for someone to “hit rock bottom” was always clinically questionable. In the current fentanyl environment, it is clinically indefensible. Rock bottom is increasingly a fatal overdose. Early intervention — before the consequences become irreversible — is not enabling; it is medicine. If you recognize the signs described in this article, the time to act is now.

Everyone in a household with someone who uses opioids should also have naloxone (Narcan) accessible and know how to use it. It is available without a prescription at most pharmacies and can be obtained for free through local harm reduction programs.

Treatment Options for Opioid Use Disorder

OUD is among the most treatable chronic conditions in medicine. SAMHSA and NIDA both identify medication-assisted treatment (MAT) as the gold standard, reducing overdose mortality by up to 50% compared to abstinence-only approaches:

  • Buprenorphine (Suboxone, Sublocade): A partial opioid agonist that eliminates withdrawal and craving without producing intoxication when taken as prescribed. Can be prescribed by a waivered physician in an office-based setting.
  • Methadone: A full opioid agonist dispensed through licensed opioid treatment programs (OTPs). Highly effective for severe OUD with daily observed dosing.
  • Naltrexone (Vivitrol): An opioid antagonist that blocks opioid effects entirely. Available as a monthly injectable. Requires full detox before initiation.

MAT works best within a comprehensive treatment structure. Depending on severity, this may include medical detox, inpatient rehab, partial hospitalization, or intensive outpatient care. For people with co-occurring depression, anxiety, PTSD, or other mental health conditions, dual diagnosis treatment addresses both simultaneously — which is critical, as untreated mental health conditions are one of the strongest predictors of relapse.

What to Do If You Recognize These Signs

  • Call (844) 561-0606 — free helpline, insurance verified same-day, same-day admissions available in most states
  • Get naloxone (Narcan) immediately — available without a prescription at most pharmacies; learn how to use it before you need it
  • Verify insurance coverage — most major insurers are required to cover OUD treatment under the ACA and MHPAEA; our specialists verify benefits at no cost
  • For family members: Ask about CRAFT (Community Reinforcement and Family Training) — the most evidence-based model for engaging a resistant loved one in treatment. Also consider Nar-Anon for family support.
  • Find a treatment program: Use our rehab directory to find facilities near you, or call and let our specialists match you with an appropriate program based on your insurance, location, and clinical needs

Treatment Can Begin Today

OUD is highly treatable. MAT reduces overdose deaths by up to 50%. Same-day admissions available. Insurance verified before referral — free, confidential call.

(844) 561-0606 — Free

Frequently Asked Questions

Physical dependence means the body has adapted to opioids and will experience withdrawal if stopped — this can happen to anyone taking opioids regularly for pain management. Opioid use disorder involves compulsive use, loss of control, and continued use despite harmful consequences. Physical dependence alone does not constitute OUD, but it does mean stopping should be done under medical supervision to manage withdrawal safely.
Yes — absolutely. Prescription opioids including oxycodone (OxyContin, Percocet), hydrocodone (Vicodin), hydromorphone (Dilaudid), and fentanyl patches all carry significant addiction potential. Many people who develop OUD began with a legitimate prescription. The DSM-5 criteria for OUD apply regardless of whether the opioid was prescribed or obtained illicitly.
NIDA recommends a minimum of 90 days of treatment for most people with OUD. Many patients remain on buprenorphine or methadone for years — which is considered appropriate evidence-based medical management, not a failure. Treatment length depends on severity, co-occurring disorders, and social support. The goal is sustained recovery, not the shortest possible treatment episode.
No. Buprenorphine is a partial opioid agonist that, when taken as prescribed, does not produce intoxication or euphoria. It stabilizes brain chemistry, eliminates withdrawal and cravings, and dramatically reduces overdose risk. ASAM, SAMHSA, and NIDA all identify it as a first-line treatment for OUD. People maintained on buprenorphine function normally, hold jobs, maintain relationships, and are not “addicted” in the behavioral sense — they are medically managed.
The most evidence-based approach is CRAFT (Community Reinforcement and Family Training), which outperforms traditional confrontational intervention models in treatment entry rates. Unlike Al-Anon (which focuses on detachment) or formal interventions (which can backfire), CRAFT gives family members specific behavioral strategies to reinforce non-use and reduce rewards for use, while strategically introducing treatment options. Call our helpline and ask about CRAFT guidance — our specialists can walk you through it.
Yes. Many treatment programs accept uninsured patients through sliding-scale fees, state-funded beds, or SAMHSA block grant funding. Medicaid covers OUD treatment at low or no cost in all 50 states — enrollment is open year-round. Call (844) 561-0606 and we’ll identify options in your area regardless of insurance status.
Opioid Addiction Signs DSM-5 OUD Family Intervention

Sources

  1. American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). psychiatry.org
  2. SAMHSA. (2023). Key Substance Use and Mental Health Indicators: 2023 NSDUH. samhsa.gov
  3. CDC. (2024). Drug Overdose Deaths in the United States 2023. cdc.gov
  4. NIDA. (2023). Principles of Drug Addiction Treatment: A Research-Based Guide. nida.nih.gov
  5. DEA. (2023). Facts About Fentanyl. dea.gov
  6. SAMHSA. (2023). Medications for Substance Use Disorders. samhsa.gov

Addiction Helpline America Clinical Team

Licensed Addiction Medicine Specialists

All content reviewed by licensed addiction medicine specialists following SAMHSA, NIDA, and ASAM guidelines. Learn about our editorial process.

Related Articles